Breast Cancer in Young Women

Chair: S. Aebi, CH
Co-Chairs: G. Freilich, UK - F.A. Peccatori, IT

ORGANISING SECRETARIAT
Roberta Ventura
CQ Travel
Via Pagliano, 37
20149 Milan, Italy
Tel: +39 02 480 49521
Fax:+39 02 43911 650
Email: eso@cq-travel.com

CONFERENCE VENUE
Inselspital
Langhaus Auditorium
Institute of Pathology H128, University of Bern
Murtenstrasse 31
CH - 3010 Bern, Switzerland

OFFICIAL LANGUAGE
The official language of the course will be English. No simultaneous translation will be provided.

CERTIFICATES
All participants will be issued with a certificate of attendance at the close of the conference.

BADGE
The badge is the only official evidence of registration and should be worn at all times during the conference. Loss of badge means loss of registration.

INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the conference. Participants are strongly advised to take out their own personal and travel insurance coverage.

CASE PRESENTATIONS
Participants are encouraged to submit a case presentation for a multidisciplinary discussion (September 3, 2010, 4:20 to 5pm). The cases should be presented with a short history, clinical findings, imaging (e.g. mammograms, ultrasound, MRI), photographs of pathology specimens, and other pertinent documentation. The cases will be presented by the participants; they should be prepared in Microsoft Power Point (or Acrobat PDF) and submitted until August 15, 2010 to Prof. Stefan Aebi (stefan.aebi@insel.ch) who will select the cases and inform the presenters.

FACULTY (as of April 2010) 

S. Aebi, University Hospital Berne, CH
J. Alder, University Hospital Basel, CH
A. Baildam, University Hospital of South Manchester, UK
B. Borisch, University of Geneva, CH
M. Eicher, Haute Ecole de Santé, Fribourg, CH
G. Freilich, Europa Donna, The European Breast Cancer Coalition, London, UK 
T. Galiardi, Aberdeen Royal Infirmary, Aberdeen, UK
O. Gentilini, European Institute of Oncology, Milan, IT
G. Gruber, Klinik Hirslanden, Zurich, CH
A. Günthert, University Hospital Berne, CH
B.A. Gusterson, Western Infirmary, University of Glasgow, UK
J. Huober, Kantonsspital, St. Gallen, CH
M.W. Kissin, Royal Surrey County Hospital, Guildford, UK
S. Loi, Jules Bordet Institute, Brussels, BE
S. Loibl, German Breast Group, Frankfurt, DE
O. Pagani, Oncology Institute of Southern Switzerland, Lugano, CH
P. Pasanisi, IRCCS Foundation, National Cancer Institute, Milan, IT
F.A. Peccatori, European Institute of Oncology, Milan, IT
E. Rapiti, University of Geneva, CH
A. Santi, University Hospital Berne, CH
S. Strasser, Kantosspital, St. Gallen, CH
M. Watson, Royal Marsden Hospital, London, UK
 

2 September

3 September